The global Drug Eluting Balloon Market is estimated to be valued at US$ 616.6 million in 2022 and is expected to exhibit a CAGR of 8.3% over the forecast period 2022-2030.

A) Market Overview:

Drug eluting balloons are medical devices used in the treatment of coronary artery disease and peripheral artery disease. These balloons are coated with anti-restenotic drugs, which are released during angioplasty to prevent the re-narrowing of the arteries. The use of drug ... Read more

Drug eluting balloons (DEBs) are regular angioplasty balloons coated with an anti-proliferative medication intended to prevent restenosis (renarrowing) of the artery. They work by locally delivering drugs, which essentially slow down rapid regrowth of tissues in arteries. DEBs minimize the risk of restenosis which is a leading cause of repeat procedures in patients with coronary or peripheral artery disease.

The global Drug Eluting Balloon Market is estimated to be ... Read more